Monday, September 30, 2019

Ranitidine controversy: Which Indian pharma companies stand to lose?

Ranitidine controversy: Which Indian pharma companies stand to lose? NULL

from Moneycontrol Business News https://ift.tt/2nRJ8ks

No comments:

Post a Comment

BSE shares jump 3% to break two-day losing streak amid Sebi board meet buzz

BSE shares experienced a surge, climbing as high as 2.7% following reports that Sebi's board meeting wouldn't address ending weekly ...